Text Size

Evaluation of the Practice of Three Morning Sputa on Separate Days for Diagnosis of Mtb

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Rany Condos, MD, New York University School of Medicine
ClinicalTrials.gov Identifier:
NCT00212550
First received: September 13, 2005
Last updated: June 20, 2012
Last verified: June 2012
History of Changes
  Purpose

Obtain sputum smears within one day to rule out TB


Condition Intervention
Pulmonary TB
 Procedure: Obtain standard three daily sputum samples vs. three samples on the first day for the diagnosis of pulmonary TB.

Study Type: Observational
Study Design: Time Perspective: Prospective

Further study details as provided by New York University School of Medicine:

Enrollment: 10
Study Start Date: November 2006
Groups/Cohorts Assigned Interventions
TB diagnosis Procedure: Obtain standard three daily sputum samples vs. three samples on the first day for the diagnosis of pulmonary TB.
Sputum induction

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

TB patients

Criteria

Inclusion Criteria:

  • All subjects admitted to Bellevue Hospital for evaluation of possible TB

Exclusion Criteria:

  • Unable to produce spontaneous or induced sputum
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00212550

Locations
United States, New York
NYU School of Medicine Division of Pulmonary and Critical Care
New York, New York, United States, 10016
Sponsors and Collaborators
New York University School of Medicine
Investigators
Principal Investigator: Rany Condos, MD NYU School of Medicine
  More Information

No publications provided

Responsible Party: Rany Condos, MD, Assistant Professor of Medicine, New York University School of Medicine
ClinicalTrials.gov Identifier: NCT00212550     History of Changes
Other Study ID Numbers: 9250-04B
Study First Received: September 13, 2005
Last Updated: June 20, 2012
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Tuberculosis, Pulmonary
Tuberculosis
Mycobacterium Infections
Actinomycetales Infections
Gram-Positive Bacterial Infections
 Bacterial Infections
Lung Diseases
Respiratory Tract Diseases
Respiratory Tract Infections

ClinicalTrials.gov processed this record on May 16, 2013